Public Health On Call

About this episode: Dr. Anita K. Patel emerged as a prominent online educator during the pandemic. Today, she's leveraging social media to advocate for the humane treatment of children in ICE detention. In this episode: her work to help detained children obtain much-needed medical attention and her advice for doctors on using social media to make a wider impact. Guest: Dr. Anita K. Patel is an att...

About this episode: An outbreak of hantavirus on a cruise ship has triggered a global public health response to treat those infected and trace those exposed. In this episode: why this type of hantavirus is unique, what the symptoms and severity are, and why experts are assuring the public that the risk of pandemic-level transmission is low. Guest: Kari Moore Debbink , PhD, MEd, is a virologist at...

About this episode: What would change if we thought of violence as an infectious disease? In this episode: a trailblazer in the movement for community-based solutions to violence, Dr. Gary Slutkin, explains how treating violence like an epidemic can point the way to solutions. Guest: Dr. Gary Slutkin is a physician and epidemiologist who founded the organization Cure Violence Global . He is also t...

About this episode: Connecting community members with nutritious foods can also open the door to other resources for improving wellbeing, from nutrition education to legal services to housing support. In this episode: Devonne Franklin and Shikera Shelton of the Y in Central Maryland talk about the organization's Fresh Mart program and how providing a good meal opens the door to improving community...

About this episode: Appointed by Mayor Zohran Mamdani earlier this year, Dr. Alister Martin is developing creative ways to make life healthier and more affordable for New Yorkers. In this episode: Dr. Martin shares how his office is meeting problems head on, finding innovative ways to connect with neighbors, and serving through a public health trust deficit. Guest: Dr. Alister F. Martin, MPP , is...

About this episode: A new vaccine shows 70% efficacy in preventing Lyme disease, but limitations to the clinical trials put the fate of this intervention in limbo. In this episode: Anna Durbin, an expert in experimental vaccines, explains where this vaccine shows promise, where it falls short, and what could happen next for licensing and regulation. Guest: Dr. Anna Durbin is a professor of Interna...

About this episode: Amid a major turning point for the field of public health, physicians and public health experts are reckoning with their approach to their work, especially in the context of public outreach. In this episode: a discussion with a preventive medicine resident who is spending a month working with the podcast team. Topics include his experiences, interplay between new media and publ...

About this episode: Many people know community health workers for their work supporting clinical care and connecting people to resources. In this episode: the role of community health workers in crafting research questions, recruiting study participants, sharing results, and making a broader impact. Guest: Donald Young Jr. is a community outreach engagement specialist for the D.C., Maryland, Virgi...

About this episode: A 2021 leak of jet fuel into the drinking water supply on O'ahu has caused neurological, gastrointestinal, and respiratory conditions and prompted outrage from community members. In this episode: the story of an in-depth investigation into the disaster, which covered how to measure exposure and support the individuals and families compromised by this crisis. Guest: Natalie Exum...

About this episode: Exacerbated by cuts to research funding and on-the-ground interventions, malaria remains one of the deadliest and most burdensome health crises across the globe. In this episode: Jane Carlton of the Johns Hopkins Malaria Research Institute details the state of the disease in 2026 and how tools like improved vaccines and genetically modified mosquitoes can bring us closer to eli...

About this episode: Following the FDA's removal of black box warnings for hormone therapy drugs, demand has skyrocketed for menopause treatments. In this episode: why this explosion in popularity marks a trend in the right direction for quality reproductive care while also raising concerns about "menowashed" products and blanket prescribing of hormonal interventions. Guests: Dr. Wendy L. Bennett ,...

About this episode: A collaboration between the Johns Hopkins Bloomberg School of Public Health, KFF Health News, and Shatterproof is tracking how communities across the country are spending opioid settlement funds. In this episode: Abigail Winiker of the Bloomberg Overdose Prevention Initiative details the good, bad, and the ugly of the expenditures the team has tracked, from EMS-delivered harm r...

About this episode: New findings suggest that, compared to adults with similar habits, teens with patterns of problematic cannabis use are at an elevated risk for developing other mental disorders like schizophrenia and depression. In this episode: Johannes Thrul breaks down a study on this potential link and outlines what it may mean for the growing field of cannabis research. Guest: Johannes Thr...

About this episode: People are increasingly turning to AI chatbots for therapeutic purposes—but these platforms are built for engagement, not mental health care. In this episode: Laura Reiley, whose daughter took her own life after confiding in a chatbot, explains why this technology is ill-equipped to treat those struggling with their mental health and how a transparent regulatory system could es...

About this episode: Humanitarian crises don't exist in a vacuum—they are shaped by geopolitical actions like blockades, sanctions, and armed conflicts between countries. In this episode: Stanford University scholar Ruth Gibson details how geopolitical decisions impact civilians on the ground and how this framing applies to current situations in Iran, Cuba, and Ukraine. Guest: Ruth Gibson , PhD, is...

About this episode: Public health efforts have led to tremendous gains throughout history—and sparked backlash. That's the argument made by Michelle A. Williams in her new book "The Cure for Everything The Epic Struggle for Public Health and a Radical Vision for Human Thriving." In this episode: why community interventions often go underappreciated, the economic benefits of a healthy society, and...

About this episode: The U.S. is on track to surpass 2025's alarming number of measles cases in 2026. At the same time, the nation's measles elimination status remains under review as health entities use genome sequencing to better understand the state of transmission. In this episode: Infectious disease specialist William Moss explains what's at stake with the verification of the U.S.'s eliminatio...

About this episode: Biosolids created by the wastewater treatment process are useful fertilizers in agriculture, but they often contain chemical compounds from the pharmaceutical and personal care products we send down our drains. In this episode: Researcher Carsten Prasse details new findings that suggest that fungi could reduce our risk of exposure to these compounds in our drinking water and fo...

About this episode: A federal judge has halted changes from the Department of Health and Human Services to the childhood immunization schedule and the Advisory Committee on Immunization Practice. In this episode: the impact of this decision and what comes next. Guest: Sarah Despres , JD, is a lawyer with over 25 years of experience in public health policy and advocacy and is an expert on immunizat...

About this episode: Prediabetes—a diagnosis characterized by elevated blood sugar levels that can progress to Type 2 diabetes—is embroiled in debate about whether the condition is clinically "real," and, if so, what the threshold for diagnosis should be. In this episode: Epidemiologist and diabetes expert Elizabeth Selvin breaks down the controversy surrounding prediabetes and why she thinks the d...

About this episode: Despite sizable decreases in tobacco use in high-income countries, 7 million people around the world die every year from tobacco-related causes. In this episode: an approach that seeks not to manage the $880 billion tobacco industry but to end it. Guest: Eline Goethals is a communications specialist and a fellow at the School of Moral Ambition. Host: Dr. Josh Sharfstein is dist...

About this episode: A neurodegenerative disease that can only be diagnosed after death, CTE has made headlines for its prevalence in professional football players. But where does it stand as a public health issue? In this episode: Jesse Mez of the Boston University CTE Center gives an overview of what we know and don't yet know about CTE, as well as tips for parents of children who play contact sp...

About this episode: As policy has shifted at the federal level, state legislatures are considering a broad range of vaccine-related bills. In this episode: Jennifer Herricks and Northe Saunders of American Families for Vaccines talk about the landscape of vaccine policy, from "medical freedom" bills to those seeking shore up vaccine access. Guests: Jennifer Herricks , PhD, is the founder of Louisi...

About this episode: In late 2025, the EPA approved two pesticides for agricultural use that opponents argue contain PFAS—"forever chemicals" that pose hazards to human health. In this episode: the debate around what constitutes PFAS and the EPA's role in regulating these harmful chemicals. Guest: Rachel Frazin covers energy and environmental policy for The Hill and is the co-author of the book " P...

About this episode: Adults with intellectual and developmental disabilities experience higher rates of anxiety and depression than those without IDDs. Barriers like cost, a lack of trained providers, and societal biases keep many from accessing the care they need. In this episode: what's fueling this crisis hidden in plain sight and what needs to change in order to fix it. Guests: Kayte Barton is...